Global Neurological Disorder Drugs Sales Market Report 2017

January 2017 | 109 pages | ID: GA18D93A151EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Neurological Disorder Drugs

Revenue, means the sales value of Neurological Disorder Drugs

This report studies sales (consumption) of Neurological Disorder Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Novartis AG
• GlaxoSmithKline plc
• Merck & Co.
• Bayer AG
• AstraZeneca
• Boehringer Ingelheim GmbH
• Teva Pharmaceutical Industries Ltd.
• F. Hoffmann-La Roche Ltd.

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Neurological Disorder Drugs in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Antipsychotic
• Hypnotic & Sedative
• Analgesics
• Anticoagulants
• Others

Split by applications, this report focuses on sales, market share and growth rate of Neurological Disorder Drugs in each application, can be divided into

• Hospital
• Clinic
• Home

Contents

Global Neurological Disorder Drugs Sales Market Report 2017

1 NEUROLOGICAL DISORDER DRUGS OVERVIEW

1.1 Product Overview and Scope of Neurological Disorder Drugs
1.2 Classification of Neurological Disorder Drugs
  1.2.1 Antipsychotic
  1.2.2 Hypnotic & Sedative
  1.2.3 Analgesics
  1.2.4 Anticoagulants
  1.2.5 Others
1.3 Application of Neurological Disorder Drugs
  1.3.1 Hospital
  1.3.2 Clinic
  1.3.3 Home
1.4 Neurological Disorder Drugs Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Neurological Disorder Drugs (2011-2021)
  1.5.1 Global Neurological Disorder Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Global Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)

2 GLOBAL NEUROLOGICAL DISORDER DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Neurological Disorder Drugs Market Competition by Manufacturers
  2.1.1 Global Neurological Disorder Drugs Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Neurological Disorder Drugs Revenue and Share by Manufacturers (2011-2016)
2.2 Global Neurological Disorder Drugs (Volume and Value) by Type
  2.2.1 Global Neurological Disorder Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Global Neurological Disorder Drugs Revenue and Market Share by Type (2011-2016)
2.3 Global Neurological Disorder Drugs (Volume and Value) by Regions
  2.3.1 Global Neurological Disorder Drugs Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Neurological Disorder Drugs Revenue and Market Share by Regions (2011-2016)
2.4 Global Neurological Disorder Drugs (Volume) by Application

3 UNITED STATES NEUROLOGICAL DISORDER DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Neurological Disorder Drugs Sales and Value (2011-2016)
  3.1.1 United States Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
  3.1.2 United States Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 United States Neurological Disorder Drugs Sales Price Trend (2011-2016)
3.2 United States Neurological Disorder Drugs Sales and Market Share by Manufacturers
3.3 United States Neurological Disorder Drugs Sales and Market Share by Type
3.4 United States Neurological Disorder Drugs Sales and Market Share by Application

4 CHINA NEUROLOGICAL DISORDER DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Neurological Disorder Drugs Sales and Value (2011-2016)
  4.1.1 China Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
  4.1.2 China Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
  4.1.3 China Neurological Disorder Drugs Sales Price Trend (2011-2016)
4.2 China Neurological Disorder Drugs Sales and Market Share by Manufacturers
4.3 China Neurological Disorder Drugs Sales and Market Share by Type
4.4 China Neurological Disorder Drugs Sales and Market Share by Application

5 EUROPE NEUROLOGICAL DISORDER DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Neurological Disorder Drugs Sales and Value (2011-2016)
  5.1.1 Europe Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
  5.1.2 Europe Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Neurological Disorder Drugs Sales Price Trend (2011-2016)
5.2 Europe Neurological Disorder Drugs Sales and Market Share by Manufacturers
5.3 Europe Neurological Disorder Drugs Sales and Market Share by Type
5.4 Europe Neurological Disorder Drugs Sales and Market Share by Application

6 JAPAN NEUROLOGICAL DISORDER DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Neurological Disorder Drugs Sales and Value (2011-2016)
  6.1.1 Japan Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Japan Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Neurological Disorder Drugs Sales Price Trend (2011-2016)
6.2 Japan Neurological Disorder Drugs Sales and Market Share by Manufacturers
6.3 Japan Neurological Disorder Drugs Sales and Market Share by Type
6.4 Japan Neurological Disorder Drugs Sales and Market Share by Application

7 SOUTHEAST ASIA NEUROLOGICAL DISORDER DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Neurological Disorder Drugs Sales and Value (2011-2016)
  7.1.1 Southeast Asia Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
  7.1.2 Southeast Asia Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
  7.1.3 Southeast Asia Neurological Disorder Drugs Sales Price Trend (2011-2016)
7.2 Southeast Asia Neurological Disorder Drugs Sales and Market Share by Manufacturers
7.3 Southeast Asia Neurological Disorder Drugs Sales and Market Share by Type
7.4 Southeast Asia Neurological Disorder Drugs Sales and Market Share by Application

8 INDIA NEUROLOGICAL DISORDER DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Neurological Disorder Drugs Sales and Value (2011-2016)
  8.1.1 India Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
  8.1.2 India Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
  8.1.3 India Neurological Disorder Drugs Sales Price Trend (2011-2016)
8.2 India Neurological Disorder Drugs Sales and Market Share by Manufacturers
8.3 India Neurological Disorder Drugs Sales and Market Share by Type
8.4 India Neurological Disorder Drugs Sales and Market Share by Application

9 GLOBAL NEUROLOGICAL DISORDER DRUGS MANUFACTURERS ANALYSIS

9.1 Novartis AG
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Neurological Disorder Drugs Product Type, Application and Specification
    9.1.2.1 Antipsychotic
    9.1.2.2 Hypnotic & Sedative
  9.1.3 Novartis AG Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.1.4 Main Business/Business Overview
9.2 GlaxoSmithKline plc
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Neurological Disorder Drugs Product Type, Application and Specification
    9.2.2.1 Antipsychotic
    9.2.2.2 Hypnotic & Sedative
  9.2.3 GlaxoSmithKline plc Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.2.4 Main Business/Business Overview
9.3 Merck & Co.
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Neurological Disorder Drugs Product Type, Application and Specification
    9.3.2.1 Antipsychotic
    9.3.2.2 Hypnotic & Sedative
  9.3.3 Merck & Co. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.3.4 Main Business/Business Overview
9.4 Bayer AG
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Neurological Disorder Drugs Product Type, Application and Specification
    9.4.2.1 Antipsychotic
    9.4.2.2 Hypnotic & Sedative
  9.4.3 Bayer AG Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.4.4 Main Business/Business Overview
9.5 AstraZeneca
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Neurological Disorder Drugs Product Type, Application and Specification
    9.5.2.1 Antipsychotic
    9.5.2.2 Hypnotic & Sedative
  9.5.3 AstraZeneca Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.5.4 Main Business/Business Overview
9.6 Boehringer Ingelheim GmbH
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Neurological Disorder Drugs Product Type, Application and Specification
    9.6.2.1 Antipsychotic
    9.6.2.2 Hypnotic & Sedative
  9.6.3 Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.6.4 Main Business/Business Overview
9.7 Teva Pharmaceutical Industries Ltd.
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Neurological Disorder Drugs Product Type, Application and Specification
    9.7.2.1 Antipsychotic
    9.7.2.2 Hypnotic & Sedative
  9.7.3 Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.7.4 Main Business/Business Overview
9.8 F. Hoffmann-La Roche Ltd.
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Neurological Disorder Drugs Product Type, Application and Specification
    9.8.2.1 Antipsychotic
    9.8.2.2 Hypnotic & Sedative
  9.8.3 F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  9.8.4 Main Business/Business Overview

10 NEUROLOGICAL DISORDER DRUGS MAUFACTURING COST ANALYSIS

10.1 Neurological Disorder Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Neurological Disorder Drugs
10.3 Manufacturing Process Analysis of Neurological Disorder Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Neurological Disorder Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Neurological Disorder Drugs Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET FORECAST (2016-2021)

14.1 Global Neurological Disorder Drugs Sales, Revenue and Price Forecast (2016-2021)
  14.1.1 Global Neurological Disorder Drugs Sales and Growth Rate Forecast (2016-2021)
  14.1.2 Global Neurological Disorder Drugs Revenue and Growth Rate Forecast (2016-2021)
  14.1.3 Global Neurological Disorder Drugs Price and Trend Forecast (2016-2021)
14.2 Global Neurological Disorder Drugs Sales, Revenue and Growth Rate Forecast by Regions (2016-2021)
  14.2.1 United States Neurological Disorder Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.2 China Neurological Disorder Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.3 Europe Neurological Disorder Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.4 Japan Neurological Disorder Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.5 Southeast Asia Neurological Disorder Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.6 India Neurological Disorder Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
14.3 Global Neurological Disorder Drugs Sales, Revenue and Price Forecast by Type (2016-2021)
14.4 Global Neurological Disorder Drugs Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neurological Disorder Drugs
Table Classification of Neurological Disorder Drugs
Figure Global Sales Market Share of Neurological Disorder Drugs by Type in 2015
Figure Antipsychotic Picture
Figure Hypnotic & Sedative Picture
Figure Analgesics Picture
Figure Anticoagulants Picture
Figure Others Picture
Table Applications of Neurological Disorder Drugs
Figure Global Sales Market Share of Neurological Disorder Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure Home Examples
Figure United States Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)
Figure China Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)
Figure India Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)
Figure Global Neurological Disorder Drugs Sales and Growth Rate (2011-2021)
Figure Global Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)
Table Global Neurological Disorder Drugs Sales of Key Manufacturers (2011-2016)
Table Global Neurological Disorder Drugs Sales Share by Manufacturers (2011-2016)
Figure 2015 Neurological Disorder Drugs Sales Share by Manufacturers
Figure 2016 Neurological Disorder Drugs Sales Share by Manufacturers
Table Global Neurological Disorder Drugs Revenue by Manufacturers (2011-2016)
Table Global Neurological Disorder Drugs Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Neurological Disorder Drugs Revenue Share by Manufacturers
Table 2016 Global Neurological Disorder Drugs Revenue Share by Manufacturers
Table Global Neurological Disorder Drugs Sales and Market Share by Type (2011-2016)
Table Global Neurological Disorder Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Neurological Disorder Drugs by Type (2011-2016)
Figure Global Neurological Disorder Drugs Sales Growth Rate by Type (2011-2016)
Table Global Neurological Disorder Drugs Revenue and Market Share by Type (2011-2016)
Table Global Neurological Disorder Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Neurological Disorder Drugs by Type (2011-2016)
Figure Global Neurological Disorder Drugs Revenue Growth Rate by Type (2011-2016)
Table Global Neurological Disorder Drugs Sales and Market Share by Regions (2011-2016)
Table Global Neurological Disorder Drugs Sales Share by Regions (2011-2016)
Figure Sales Market Share of Neurological Disorder Drugs by Regions (2011-2016)
Figure Global Neurological Disorder Drugs Sales Growth Rate by Regions (2011-2016)
Table Global Neurological Disorder Drugs Revenue and Market Share by Regions (2011-2016)
Table Global Neurological Disorder Drugs Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Neurological Disorder Drugs by Regions (2011-2016)
Figure Global Neurological Disorder Drugs Revenue Growth Rate by Regions (2011-2016)
Table Global Neurological Disorder Drugs Sales and Market Share by Application (2011-2016)
Table Global Neurological Disorder Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Neurological Disorder Drugs by Application (2011-2016)
Figure Global Neurological Disorder Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
Figure United States Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
Figure United States Neurological Disorder Drugs Sales Price Trend (2011-2016)
Table United States Neurological Disorder Drugs Sales by Manufacturers (2011-2016)
Table United States Neurological Disorder Drugs Market Share by Manufacturers (2011-2016)
Table United States Neurological Disorder Drugs Sales by Type (2011-2016)
Table United States Neurological Disorder Drugs Market Share by Type (2011-2016)
Table United States Neurological Disorder Drugs Sales by Application (2011-2016)
Table United States Neurological Disorder Drugs Market Share by Application (2011-2016)
Figure China Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
Figure China Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
Figure China Neurological Disorder Drugs Sales Price Trend (2011-2016)
Table China Neurological Disorder Drugs Sales by Manufacturers (2011-2016)
Table China Neurological Disorder Drugs Market Share by Manufacturers (2011-2016)
Table China Neurological Disorder Drugs Sales by Type (2011-2016)
Table China Neurological Disorder Drugs Market Share by Type (2011-2016)
Table China Neurological Disorder Drugs Sales by Application (2011-2016)
Table China Neurological Disorder Drugs Market Share by Application (2011-2016)
Figure Europe Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
Figure Europe Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
Figure Europe Neurological Disorder Drugs Sales Price Trend (2011-2016)
Table Europe Neurological Disorder Drugs Sales by Manufacturers (2011-2016)
Table Europe Neurological Disorder Drugs Market Share by Manufacturers (2011-2016)
Table Europe Neurological Disorder Drugs Sales by Type (2011-2016)
Table Europe Neurological Disorder Drugs Market Share by Type (2011-2016)
Table Europe Neurological Disorder Drugs Sales by Application (2011-2016)
Table Europe Neurological Disorder Drugs Market Share by Application (2011-2016)
Figure Japan Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
Figure Japan Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
Figure Japan Neurological Disorder Drugs Sales Price Trend (2011-2016)
Table Japan Neurological Disorder Drugs Sales by Manufacturers (2011-2016)
Table Japan Neurological Disorder Drugs Market Share by Manufacturers (2011-2016)
Table Japan Neurological Disorder Drugs Sales by Type (2011-2016)
Table Japan Neurological Disorder Drugs Market Share by Type (2011-2016)
Table Japan Neurological Disorder Drugs Sales by Application (2011-2016)
Table Japan Neurological Disorder Drugs Market Share by Application (2011-2016)
Figure Southeast Asia Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
Figure Southeast Asia Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Neurological Disorder Drugs Sales Price Trend (2011-2016)
Table Southeast Asia Neurological Disorder Drugs Sales by Manufacturers (2011-2016)
Table Southeast Asia Neurological Disorder Drugs Market Share by Manufacturers (2011-2016)
Table Southeast Asia Neurological Disorder Drugs Sales by Type (2011-2016)
Table Southeast Asia Neurological Disorder Drugs Market Share by Type (2011-2016)
Table Southeast Asia Neurological Disorder Drugs Sales by Application (2011-2016)
Table Southeast Asia Neurological Disorder Drugs Market Share by Application (2011-2016)
Figure India Neurological Disorder Drugs Sales and Growth Rate (2011-2016)
Figure India Neurological Disorder Drugs Revenue and Growth Rate (2011-2016)
Figure India Neurological Disorder Drugs Sales Price Trend (2011-2016)
Table India Neurological Disorder Drugs Sales by Manufacturers (2011-2016)
Table India Neurological Disorder Drugs Market Share by Manufacturers (2011-2016)
Table India Neurological Disorder Drugs Sales by Type (2011-2016)
Table India Neurological Disorder Drugs Market Share by Type (2011-2016)
Table India Neurological Disorder Drugs Sales by Application (2011-2016)
Table India Neurological Disorder Drugs Market Share by Application (2011-2016)
Table Novartis AG Basic Information List
Table Novartis AG Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG Neurological Disorder Drugs Global Market Share (2011-2016)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline plc Neurological Disorder Drugs Global Market Share (2011-2016)
Table Merck & Co. Basic Information List
Table Merck & Co. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co. Neurological Disorder Drugs Global Market Share (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer AG Neurological Disorder Drugs Global Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Neurological Disorder Drugs Global Market Share (2011-2016)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim GmbH Neurological Disorder Drugs Global Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. Basic Information List
Table Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Global Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurological Disorder Drugs
Figure Manufacturing Process Analysis of Neurological Disorder Drugs
Figure Neurological Disorder Drugs Industrial Chain Analysis
Table Raw Materials Sources of Neurological Disorder Drugs Major Manufacturers in 2015
Table Major Buyers of Neurological Disorder Drugs
Table Distributors/Traders List
Figure Global Neurological Disorder Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Global Neurological Disorder Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Neurological Disorder Drugs Sales Forecast by Regions (2016-2021)
Table Global Neurological Disorder Drugs Sales Forecast by Type (2016-2021)
Table Global Neurological Disorder Drugs Sales Forecast by Application (2016-2021)